Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
To invite people, share this page:
About This Webinar

Through its latest acquisition of MaSTherCell, Catalent is uniquely positioned as a full-service provider of cell and gene therapy development and manufacturing services. Catalent’s experience in autologous and allogeneic cell therapy complements its industry-leading expertise and commercial success in gene therapy development, manufacturing and adeno-associated virus (AAV) vector production. Its cell therapy offering includes expertise with a variety of cell types including chimeric antigen receptor T cells (CAR-T). With facilities in the US and Europe and continued new investments, Catalent is dedicated to supporting its customers and their patients. Catalent has produced more than 100 cGMP batches across 60+ clinical and commercial programs.

Categories:
SCIENCE & TECH
Language: English
Who can attend? Everyone
Featured Presenters
Webinar hosting presenter
Catalent Cell & Gene Therapy - Business Developer
Webinar hosting presenter
Catalent Cell & Gene Therapy - Global Product Manager, Gene Therapy
Webinar hosting presenter
Catalent Cell & Gene Therapy - Director, Business Development
Webinar hosting presenter
Catalent Cell & Gene Therapy - Business Developer
Webinar hosting presenter
Marketing Manager
Webinar hosting presenter
Catalent Cell & Gene Therapy - Chief Commercial Officer
Webinar hosting presenter
Catalent Cell & Gene Therapy - Global Group Product Manager, Cell Therapy
Hosted By
ASGCT 23rd Annual Meeting  webinar platform hosts Catalent Cell & Gene Therapy
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents